Patient
SITE003-0163
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE003 (CAN) (Dr. Okafor)
consented 2026-03-12
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 5
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-12-18 (study day 87); relationship: NOT RELATED
Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-12-12 (study day 81); relationship: not assessed
Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-11-09 (study day 48); relationship: NOT RELATED
Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-10-09 (study day 17); relationship: not assessed
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-10-07 (study day 15); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.